Deep Learning Approaches for Automated Prediction of Treatment Response in Non-Small-Cell Lung Cancer Patients Based on CT and PET Imaging

The rapid growth of artificial intelligence, particularly in the field of deep learning, has opened up new advances in analyzing and processing large and complex datasets. Prospects and emerging trends in this area engage the development of methods, techniques, and algorithms to build autonomous sys...

Full description

Saved in:
Bibliographic Details
Main Authors: Randy Guzmán Gómez, Guadalupe Lopez Lopez, Victor M. Alvarado, Froylan Lopez Lopez, Eréndira Esqueda Cisneros, Hazel López Moreno
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Tomography
Subjects:
Online Access:https://www.mdpi.com/2379-139X/11/7/78
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The rapid growth of artificial intelligence, particularly in the field of deep learning, has opened up new advances in analyzing and processing large and complex datasets. Prospects and emerging trends in this area engage the development of methods, techniques, and algorithms to build autonomous systems that perform tasks with minimal human action. In medical practice, radiological imaging technologies systematically boost progress in the clinical monitoring of cancer through the information that can be analyzed in these images. This review gives insight into deep learning-based approaches that strengthen the assessment of the response to the treatment of non-small-cell lung cancer. This systematic survey delves into the various approaches to morphological and metabolic changes observed in computerized tomography (CT) and positron emission tomography (PET) imaging. We highlight the challenges and opportunities for feasible integration of deep learning computer-based tools in evaluating treatments in lung cancer patients, after which CT and PET-based strategies are contrasted. The investigated deep learning methods are organized and described as instruments for classification, clustering, and prediction, which can contribute to the design of automated and objective assessment of lung tumor responses to treatments.
ISSN:2379-1381
2379-139X